Norgestimate, ethinyl estradiol drug combination
Showing 9976 - 10000 of >10,000
Graft-versus-host Disease (GVHD) Trial in United States (Ruxolitinib, Prednisone or methylprednisolone)
Completed
- Graft-versus-host Disease (GVHD)
- Ruxolitinib
- Prednisone or methylprednisolone
-
Tucson, Arizona
- +37 more
Oct 28, 2021
Advanced or Metastatic Non-squamous Non-small-cell Lung Cancer Trial (SHR-1701 + Pemetrexed Disodium + cisplatin/carboplatin +
Not yet recruiting
- Advanced or Metastatic Non-squamous Non-small-cell Lung Cancer
- SHR-1701 + Pemetrexed Disodium + cisplatin/carboplatin + bevacizumab
- +2 more
- (no location specified)
Nov 12, 2021
AML, Acute Myeloid Leukemia Trial in Charlottesville (Cardioprotection)
Recruiting
- AML
- Acute Myeloid Leukemia
-
Charlottesville, VirginiaUniversity of Virginia
Jul 2, 2022
Breast Cancer, Metastasis Trial in New York (Abemaciclib, Bicalutamide)
Recruiting
- Breast Cancer
- Metastasis
-
New York, New York
- +2 more
Oct 14, 2021
Breast Cancer Trial in Boston (Ipatasertib, Fulvestrant, Aromatase Inhibitor)
Recruiting
- Breast Cancer
- Ipatasertib
- +3 more
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Oct 25, 2021
Progesterone Levels During Ovulation and Luteal Phase
Recruiting
- Infertility, Female
- human chorionic gonadotropin
-
Abu Dhabi, United Arab EmiratesART Fertility Clinics LLC
Oct 10, 2021
Diabetic Patients, Type II Diabetes Trial in Sevilla (OA-enriched functional olive oil, commercial olive oil)
Recruiting
- Diabetic Patients
- Type II Diabetes Mellitus
- OA-enriched functional olive oil
- commercial olive oil
-
Sevilla, Andalicía, SpainVirgen del Rocío University Hospital
Sep 1, 2023
Bone Resistant Tuberculosis
Completed
- Bone and Osteoarticular Infection Due to MDR M. Tuberculosis Strains
- Descriptive retrospective study
-
Paris, FrancePitié Salpêtrière Hospital
May 9, 2022
Pancreas Cancer Trial in Louisville (Irreversible Electroporation (IRE), Gemcitabine, FOLFIRINOX)
Recruiting
- Pancreas Cancer
- Irreversible Electroporation (IRE)
- +2 more
-
Louisville, KentuckyUniversity of Louisville
Oct 6, 2021
Paroxysmal Sympathetic Hyperactivity Trial (Percutaneous Electrical Nerve Field Stimulation (PENFS) device application)
Not yet recruiting
- Paroxysmal Sympathetic Hyperactivity
- Percutaneous Electrical Nerve Field Stimulation (PENFS) device application
- (no location specified)
Apr 19, 2022
NSCLC, Lung Cancer, NSCLC Trial in United States (G1T38, Osimertinib)
Completed
- Carcinoma, Non-Small-Cell Lung
- +2 more
-
Beverly Hills, California
- +7 more
Sep 20, 2022
Acute Myelogenous Leukemia, MDS, Mixed Phenotype Acute Leukemia Trial (Fludarabine, Cytarabine, Uproleselan)
Not yet recruiting
- Acute Myelogenous Leukemia
- +2 more
- Fludarabine
- +2 more
- (no location specified)
Mar 3, 2022
AML Trial in Puerto Rico, United States (Cytarabine (Phase 1 only), Lintuzumab-Ac225, Furosemide (Phase 1 only))
Completed
- AML
- Cytarabine (Phase 1 only)
- +3 more
-
Los Angeles, California
- +16 more
Feb 22, 2022
Urothelial/Bladder Cancer, Nos Trial in New York (Atezolizumab, PGV001, Poly ICLC)
Completed
- Urothelial/Bladder Cancer, Nos
- Atezolizumab
- +3 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Mar 7, 2022
Sleep Apnea, Obstructive Trial in Baton Rouge (Metformin, Placebo oral capsule)
Completed
- Sleep Apnea, Obstructive
- Metformin
- Placebo oral capsule
-
Baton Rouge, LouisianaRecruiting core Pennington
Mar 11, 2022
Esophageal Squamous Cell Carcinoma Trial in Worldwide (Durvalumab, Placebo, cisplatin + fluorouracil)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Durvalumab
- +4 more
-
Tucson, Arizona
- +165 more
Jan 18, 2023
Pulmonary Hypertension Due to Left Heart Disease Trial in Washington, Columbus, Pittsburgh (Treprostinil Diolamine)
Not yet recruiting
- Pulmonary Hypertension Due to Left Heart Disease
- Treprostinil Diolamine
-
Washington, District of Columbia
- +2 more
May 10, 2022
FimasaRtan-basEd BP Targets After Drug SwitcHing
Completed
- Essential Hypertension
-
Suwon, Korea, Republic ofAjou University Hospital
Dec 22, 2020
Head Neck Cancer Trial in Boston (Oral Decitabine, Durvalumab)
Active, not recruiting
- Head and Neck Cancer
- Oral Decitabine
- Durvalumab
-
Boston, MassachusettsMassachusetts General Hospital
Oct 30, 2022
Beta Thalassaemia Trial in Milan (Safety and Efficacy assessments)
Active, not recruiting
- Beta Thalassaemia
- Safety and Efficacy assessments
-
Milan, ItalyOspedale San Raffaele - Telethon Institute for Gene Therapy (OSR
Nov 22, 2022
Breast Cancer Stage IV Trial in Houston (Simvastatin 80mg)
Recruiting
- Breast Cancer Stage IV
- Simvastatin 80mg
-
Houston, Texas
- +1 more
Apr 1, 2022
C-reactive Protein(CRP) Levels and Life Quality in Natural
Completed
- CRP
- Menopause
- (no location specified)
Jun 25, 2020
Metastatic Breast Cancer Trial in United States (Pertuzumab, Trastuzumab)
Completed
- Metastatic Breast Cancer
-
Tucson, Arizona
- +15 more
Dec 3, 2021
Heart Failure Trial (Dapagliflozin 10mg Tab)
Not yet recruiting
- Heart Failure
- Dapagliflozin 10mg Tab
- (no location specified)
Feb 14, 2023